Literature DB >> 15063765

Regulatory role of vHL/HIF-1alpha in hypoxia-induced VEGF production in hepatic stellate cells.

Yang Q Wang1, John M Luk, Kazuo Ikeda, Kwan Man, Andrew C Chu, Kenji Kaneda, Sheung Tat Fan.   

Abstract

Activated hepatic stellate cells (HSCs) produce cyclooxygenase-2 (COX-2) protein to induce vascular endothelial growth factor (VEGF) production that participates in angiogenesis in injured liver. To reveal the unknown regulatory mechanism, we used hypoxic atmosphere mimicking injured-tissue microenvironment to induce VEGF expression in a rat hepatic stellate cell line (T6-HSCs). The present study showed that hypoxia up-regulated the protein levels of COX-2 and hypoxia-inducible factor-1-alpha (HIF-1alpha), but rapidly effected degradation of von Hippel-Lindau (vHL) protein. As a result, expression of VEGF in HSCs was markedly elevated; and pretreatment with COX-2 inhibitors (nimesulide or indomethacin) could significantly ameliorate the angiogenic event. Collectively, hypoxic HSCs increased accumulation of HIF-1alpha protein and induced VEGF expression in a time-dependent manner. Inhibition of COX-2 activities would prevent vHL protein from degradation and suppress HIF-1alpha up-regulation. Thus, vHL/HIF-1alpha has a regulatory role in COX-2-mediated VEGF production in hypoxic stellate cells in injured liver.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063765     DOI: 10.1016/j.bbrc.2004.03.050

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

Review 1.  Novel kinase inhibitors in renal cell carcinoma: progressive development of static agents.

Authors:  Apurva A Desai; Walter M Stadler
Journal:  Curr Oncol Rep       Date:  2005-03       Impact factor: 5.075

Review 2.  Angiogenesis and liver fibrosis.

Authors:  Gülsüm Özlem Elpek
Journal:  World J Hepatol       Date:  2015-03-27

3.  Angiogenesis: a phenomenon which aggravates chronic liver disease progression.

Authors:  Michał Kukla
Journal:  Hepatol Int       Date:  2012-07-26       Impact factor: 6.047

4.  Inhibition of endothelial cell proliferation and tumor angiogenesis by up-regulating NDRG2 expression in breast cancer cells.

Authors:  Ji Ma; Wenchao Liu; Xiaohong Yan; Qianrong Wang; Qingli Zhao; Yan Xue; Hui Ren; Lin Wu; Yuanxiong Cheng; Sen Li; Lu Miao; Libo Yao; Jian Zhang
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

5.  Hepatic stellate cells produce vascular endothelial growth factor via phospho-p44/42 mitogen-activated protein kinase/cyclooxygenase-2 pathway.

Authors:  Yi Zhao; Yanqing Wang; Qiang Wang; Zhengrong Liu; Qingfeng Liu; Xin Deng
Journal:  Mol Cell Biochem       Date:  2011-08-24       Impact factor: 3.396

Review 6.  Mechanisms of liver fibrosis and its role in liver cancer.

Authors:  Debanjan Dhar; Jacopo Baglieri; Tatiana Kisseleva; David A Brenner
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-10

Review 7.  Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do!

Authors:  T Gaber; R Dziurla; R Tripmacher; G R Burmester; F Buttgereit
Journal:  Ann Rheum Dis       Date:  2005-03-30       Impact factor: 19.103

8.  All-trans retinoic acid preconditioning enhances proliferation, angiogenesis and migration of mesenchymal stem cell in vitro and enhances wound repair in vivo.

Authors:  M Pourjafar; M Saidijam; K Mansouri; H Ghasemibasir; F Karimi Dermani; R Najafi
Journal:  Cell Prolif       Date:  2016-11-10       Impact factor: 6.831

9.  Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseases.

Authors:  Claudia Paternostro; Ezio David; Erica Novo; Maurizio Parola
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

10.  Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis.

Authors:  Yosui Tamaki; Yukiomi Nakade; Taeko Yamauchi; Yuichi Makino; Shiro Yokohama; Mitsuyoshi Okada; Kazunobu Aso; Hiroyuki Kanamori; Tomohiko Ohashi; Ken Sato; Haruhisa Nakao; Masakazu Haneda; Masashi Yoneda
Journal:  J Gastroenterol       Date:  2012-08-14       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.